cyclohexanol has been researched along with Briquet Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (83.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, CI; Liu, CY; Wang, SJ | 1 |
| Masand, PS; Pae, CU; Patkar, AA; Seo, HJ; Sohi, MS | 1 |
| Liu, X; Mullins, CD; Wang, J | 1 |
| Hackett, D; Lader, M; Meoni, P | 1 |
| Lang, AE; Voon, V | 1 |
| Benattia, I; Graepel, J; Kroenke, K; Messina, N; Musgnung, J | 1 |
| Ahmed, S; Haudiquet, V; Stahl, SM | 1 |
| Alpert, JE; Balasubramani, GK; Biggs, MM; Carmin, CN; Fava, M; Howland, R; Leuchter, A; Rush, AJ; Trivedi, MH; Warden, D; Wisniewski, SR; Zisook, S | 1 |
| Begré, S; Gerber, M; Traber, M; von Känel, R | 1 |
| Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Riquier, F; Zullino, DF | 1 |
1 review(s) available for cyclohexanol and Briquet Syndrome
| Article | Year |
|---|---|
Desvenlafaxine succinate: a newer antidepressant for the treatment of depression and somatic symptoms.
Topics: Antidepressive Agents; Cyclohexanols; Depressive Disorder; Desvenlafaxine Succinate; Humans; Neurotransmitter Uptake Inhibitors; Receptors, Adrenergic; Somatoform Disorders; Vasomotor System | 2010 |
6 trial(s) available for cyclohexanol and Briquet Syndrome
| Article | Year |
|---|---|
Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Psychometrics; Somatoform Disorders; Venlafaxine Hydrochloride | 2004 |
Antidepressant treatment outcomes of psychogenic movement disorder.
Topics: Adult; Ambulatory Care; Anxiety Disorders; Chronic Disease; Citalopram; Combined Modality Therapy; Comorbidity; Conversion Disorder; Cyclohexanols; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Hypochondriasis; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.
Topics: Ambulatory Care; Anxiety Disorders; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER.
Topics: Adult; Anxiety Disorders; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Venlafaxine Hydrochloride | 2007 |
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Anxiety Disorders; Citalopram; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning | 2008 |
5 other study(ies) available for cyclohexanol and Briquet Syndrome
| Article | Year |
|---|---|
Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder.
Topics: Adolescent; Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypnotics and Sedatives; Male; Middle Aged; Observer Variation; Personality Inventory; Psychometrics; Pyridines; Reproducibility of Results; Somatoform Disorders; Taiwan; Venlafaxine Hydrochloride; Young Adult; Zolpidem | 2009 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2011 |
[Not neglecting therapy of depression in the elderly].
Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Somatoform Disorders; Venlafaxine Hydrochloride | 2006 |
Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Primary Health Care; Somatoform Disorders; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Venlafaxine and vivid dreaming.
Topics: Adult; Cyclohexanols; Dreams; Female; Humans; Sleep Wake Disorders; Somatoform Disorders; Venlafaxine Hydrochloride | 2000 |